(a) Schematic overview of the study design. Immune cells were isolated from septum, choroid plexus and blood samples. Cells were then fixed, barcoded, stained and acquired on a CyTOF Helios system …
Clinical parameters of the septum samples. Age and PMD (postmortem delay): pairwise comparisons using Wilcoxon rank-sum test with continuity correction; p-values adjusted with Benjamini-Hochberg …
(a) UMAP plots based on the arcsinh-transformed expression of all markers in the reference sample that were stained together with barcoded runs of septum, choroid plexus and blood samples. A total …
(a) Bar plot showing the number of cells used for clustering from each septum sample. A threshold was set at the 75th percentile to avoid over-representation of certain samples in the analysis. (b) …
(a) UMAPs displaying pre-gated myeloid subpopulation in the septum. The cells are colored according to PARC-guided clustering. (b) Median marker intensities of pre-selected markers across myeloid …
Dot plots show the significant correlations (p<0.05) between the percentage of the septum-derived immune cells and sample parameters. Non-normally distributed data: Spearman’s rank correlation rho; …
(a) Median scaled intensities of the ‘type’ markers across T cell subpopulations in the septum. The horizontal gray bars show the percentage of each cluster out of the total investigated cells. The …
(a) Delta area (‘elbow’) plot indicating the relative increase in cluster stability when clustering into k groups the 100 SOM clusters generated by FlowSOM. CDF: Consensus Cumulative Distribution …
Dot plots show the significant correlations (p<0.05) found between the percentage of the T cell subsets of the septum and clinical sample parameters. Spearman’s rank correlation rho is shown for …
(a) Median scaled intensities of the ‘state’ markers in NK cells across all septum samples. Column annotation shows disease groups; row annotation shows adjusted p-values of comparing MS vs dementia …
(a) Delta area (‘elbow’) plot indicating the relative increase in cluster stability when clustering into k groups the 100 SOM clusters generated by FlowSOM in the NK and B cell populations. CDF: …
(a) UMAPs displaying pre-gated CD56bright NK subpopulation in the septum. The cells are colored according to PARC-guided clustering. (b) Median marker intensities of pre-selected markers across …
Boxplots display the median marker expression of CD25 and CD49d in T-bet- B cells from the septum. *adjusted p<0.1. Con: controls; Dem: dementia; MS: multiple sclerosis. Source data is listed in Sour…
Dot plots show the significant correlations (p<0.05) found between the percentage of the septum NK and B cell subsets and clinical sample parameters. ** p<0.01. Spearman’s rank correlation rho is …
(a) UMAP plot based on the arcsinh-transformed expression of the ‘type’ (lineage) markers in the choroid plexus-derived immune cells. A subset of 1000 randomly selected cells per sample is shown, …
Clinical parameters of the choroid plexus samples. Age and PMD (postmortem delay): pairwise comparisons using Wilcoxon rank-sum test with continuity correction; p-values adjusted with …
(a) Bar plot of the number of cells used for clustering from each choroid plexus sample. A threshold was set at the 75th percentile to avoid over-representation of certain samples. (b) Delta area …
(a) Median scaled intensities of the ‘type’ markers across T cell subsets in the choroid plexus. The table shows tentative biological names of the T cell subpopulations. (b) Median scaled …
(a) Median scaled intensities of the ‘type’ markers across T cell clusters of the choroid plexus obtained with FlowSOM and ConsensusClusterPlus. (b) Percentage of each annotated cell population out …
(a) UMAP plot based on the arcsinh-transformed expression of all markers in the immune cells of the septum, choroid plexus, and blood. A total of 100,000 randomly selected cells were selected per …
Clinical parameters of the blood samples. Age and PMD (post-mortem delay): pairwise comparisons using Wilcoxon rank-sum test with continuity correction; p-values adjusted with Benjamini-Hochberg …
(a) Bar plot of the number of cells used for clustering from each blood sample. A threshold was set at the 75th percentile to avoid over-representation of certain samples. (b) Delta area (‘elbow’) …
(a) Median scaled intensities of the ‘type’ markers across T cell subpopulations in blood. Table shows tentative biological names of the T cell subpopulations. (b) Median scaled intensities of the …
(a) Median scaled intensities of the ‘type’ markers across T cell clusters in the blood obtained with FlowSOM and ConsensusClusterPlus. (b) Percentage of each annotated cell population out of the …
(a) Median scaled intensities of the ‘type’ markers across NK and B cell lineage populations in the blood obtained with FlowSOM and ConsensusClusterPlus. (b) Spearman correlation matrix of the …
(a) Representative immunohistochemical staining of myelin with proteolipid protein (PLP) and presence of immune cells with HLA-DR. The overview shows the location of the normal-appearing white …
(a) UMAPs displaying pre-gated CD56bright NK subpopulation in the septum. The cells are coloured according to PARC-guided clustering. (b) Median marker intensities of pre-selected markers across …
Positive correlations are displayed in red and negative correlations in blue. The size of the circle is proportional to the correlation coefficients. P-values adjusted with Benjamini-Hochberg …
Donor | Yield (cells/mg) | Condition |
---|---|---|
2018-120 | 4782.3 | Control |
2018-123 | 1666.2 | Control |
2019-054 | 3231.4 | Control |
2019-079 | 3596.2 | Control |
2020-003 | 4861.1 | Control |
2020-028 | 1110.4 | Control |
2019-030 | 3286.3 | Dementia |
2020-013 | 3607.5 | Dementia |
2019-016 | 3052.9 | MS |
2019-027 | 2183.0 | MS |
2019-031 | 6232.0 | MS |
2019-069 | 3175.9 | MS |
2019-107 | 2288.9 | MS |
2019-109 | 1345.3 | MS |
2019-110 | 2846.6 | MS |
Information of the donors used in this study.
Antibody panel used for CyTOF.
Details of antibodies used for multiplex immunohistochemistry.
Percentage of each annotated cell population out of the total CD45+ cells from the choroid plexus of controls (Con), dementia (AD) and multiple sclerosis (MS) donors.
Median scaled intensities of the “state” (phenotype) markers for each cell population.
Percentage of each annotated cell population out of the total CD45+ cells from the choroid plexus of controls (Con), dementia (AD) and multiple sclerosis (MS) donors.
Median scaled intensities of the “state” (phenotype) markers for each cell population.
Percentage of each annotated cell population out of the total CD45+ cells from the blood of controls (Con), dementia (AD) and multiple sclerosis (MS) donors.
Median scaled intensities of the “state” (phenotype) markers for each cell population.